Eton Pharmaceuticals, Inc. (ETON) Q1 2024 Earnings
ETON·Reported May 9, 2024·After market close
Eton Pharmaceuticals, Inc. reported Q1 2024 revenue of $8.0M, missed analyst consensus of $8.8M by $834.0K. Diluted EPS came in at $-0.03, beat the $-0.07 consensus by $0.04.
Revenue
$8.0Mmissed by $834.0K
Consensus: $8.8MDiluted EPS
$-0.03beat by $0.04
Consensus: $-0.07
Financial Snapshot
Trailing eight quarters through Q1 2024
Q1 2024 Earnings FAQ
Common questions about Eton Pharmaceuticals, Inc.'s Q1 2024 earnings report.
Eton Pharmaceuticals, Inc. (ETON) reported Q1 2024 earnings on May 9, 2024 after market close.
Eton Pharmaceuticals, Inc. reported revenue of $8.0M and diluted EPS of $-0.03 for Q1 2024.
Revenue missed the consensus estimate of $8.8M by $834.0K. EPS beat the consensus estimate of $-0.07 by $0.04.
You can read the 10-Q periodic report (0001437749-24-015697) directly on SEC EDGAR. The filing index links above go to sec.gov.